Announcements Trials

Browse Landscape

Phase

Phase NA 34 Phase 4 4 Phase 2/3 4 Phase 3 2 Phase 1 2 Phase 2 1

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Gastrointestinal 1

Conditions

Colorectal Neoplasms 1290 Pancreatic Neoplasms 818 Carcinoma, Hepatocellular 782 Stomach Neoplasms 753 Rectal Neoplasms 563 Esophageal Neoplasms 450 Colonic Neoplasms 414 Esophageal Squamous Cell Carcinoma 275 Neoplasm Metastasis 263 Cholangiocarcinoma 248 Liver Neoplasms 219 Neoplasms 199 Biliary Tract Neoplasms 179 Adenocarcinoma Of Esophagus 139 Gastrointestinal Stromal Tumors 108 Gallbladder Neoplasms 95 Adenocarcinoma 94 Gastrointestinal Neoplasms 89 Breast Neoplasms 89 Carcinoma, Non-Small-Cell Lung 86 Bile Duct Neoplasms 69 Sarcoma 67 Lung Neoplasms 63 Ovarian Neoplasms 60 Anus Neoplasms 59 Melanoma 54 Uterine Cervical Neoplasms 51 Carcinoma 48 Digestive System Neoplasms 45 Prostatic Neoplasms 39

Interventions

eicosapentaenoic acid ethyl ester 1 Fatty Acids, Omega-3 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

Clinical Trials

1 trials

Recent Start date Enrollment

Phase 2 × Polyps × Gastrointestinal × Clear all

NCT03661047 2021-11-17

OMICC

Massachusetts General Hospital

Phase 2 Withdrawn

Gastrointestinal

Colonic Neoplasms, Polyps, Colorectal Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon ⚡